BioSpace News Archive

Mission Bio, the pioneer in single-cell DNA and multi-omics analysis, announced the availability of the Tapestri® VCN Assay, the first high-throughput commercial single-cell assay to simultaneously quantify VCN and transduction at the level of individual cells.

The latest market analysis report published by Reports and Data, titled ‘Global Hepatitis C Virus Treatment Market – Forecast to 2030,’ thoroughly examines the Hepatitis C Virus Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Inflammatory Pain Treatment Market – Forecast to 2030,’ thoroughly examines the Inflammatory Pain Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Thrombocytopenia Market – Forecast to 2030,’ thoroughly examines the Thrombocytopenia industry to provide essential data & information for the targeted readers.

According to Nova one advisor, the global Overactive Bladder Treatment (OAB) market size is expected to hit around USD 8.2 billion by 2030 from valued at USD 3.9 billion in 2022 and growing at a CAGR of 4.6% from 2022 to 2030.

CSL Seqirus announced that the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, selected CSL Seqirus to deliver an H5N8 A/Astrakhan virus vaccine candidate for assessment in a Phase 2 clinical study that is anticipated to begin in Q2 2023.

Gemina Laboratories Ltd. is pleased to announce that it has entered into agreement with International Point of Care, Inc, for the manufacturing of its Legio XTM COVID-19 Rapid Antigen Test.

Octapharma announced today the results from the ProDERM study on the efficacy and safety of octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in the New England Journal of Medicine (Aggarwal R et al. “Efficacy and safety of intravenous immunoglobulin in dermatomyositis”).

Parallel ENT & Allergy Partners has added a second state to its roster of high-quality, innovative ENT and allergy partners with the addition of Grand Rapids ENT.

The National Kidney Foundation has launched a new animated video series aimed at educating people on their chronic kidney disease risk.